News & Events


  • 01 Mar 2017

    Hll To Provide Diagnostic Services In Maharashtra Hospitals In Pact With Maharashtra Government

    Expanding its Hindlabs chain of pathology and imaging facilities, HLL Lifecare Ltd has signed an agreement with the Maharashtra government for providing diagnostic services in state-run health facilities. The agreement was signed by R P Khandelwal, CMD, HLL, Dr. Pradeep Vyas, Commissioner and MD, SHS, and Dr Sathish Pawar, Director of Health Services), in Mumbai .

    As part of the agreement, HLL, a mini Ratna PSU of the Union ministry of Health and Family Welfare (MoHFW), will establish around 100 Hindlabs in 33 districts of Maharashtra for providing laboratory testing services in nearly 2,300 t hospitals under DHS, particularly at the level of Primary Health Centres (PHCs), a HLL release said today. HLL will implement the project within a period of 90 days, commencing the lab services to the general public.

    The project will be monitored by IT-enabled systems which track the details of patients samples taken from the collection centres to the lab for testing and reporting. The latest module of laboratory information system software will be used for the project to create an online dash board to view the current status of sample collection, testing and reporting from all the government hospital centers in Maharashtra.

    By implementing this project, diagnostic tests will be made available to the public in the remotest villages of Maharashtra. The labs of HLL, with sophisticated equipment, qualified manpower and IT-enabled support systems, will ensure the quality of laboratory investigations. The labs being set up under the project will have all the divisions like hematology, pathology, biochemistry, immunoassay and microbiology, Mr. Khandelwal said.

    HLL is implementing similar projects in Assam, Kerala and Odisha, partnering with National Health Mission (NHM).

    Hindlabs offers more than 100 tests from the hospital centres, including the high end special molecular diagnostic tests, at rates much lower than market prices.